These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21176238)

  • 21. [Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes].
    Fu XY; Tan DM; Hou ZH; Hu ZL; Liu GZ; Ouyang Y; Liu F
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):598-604. PubMed ID: 23207154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-200a and -200b mediated hepatocellular carcinoma cell migration through the epithelial to mesenchymal transition markers.
    Hung CS; Liu HH; Liu JJ; Yeh CT; Chang TC; Wu CH; Ho YS; Wei PL; Chang YJ
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S360-8. PubMed ID: 22868917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-125a/b inhibits tumor-associated macrophages mediated in cancer stem cells of hepatocellular carcinoma by targeting CD90.
    Wang Y; Wang B; Xiao S; Li Y; Chen Q
    J Cell Biochem; 2019 Mar; 120(3):3046-3055. PubMed ID: 30536969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
    Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
    Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
    Ladeiro Y; Couchy G; Balabaud C; Bioulac-Sage P; Pelletier L; Rebouissou S; Zucman-Rossi J
    Hepatology; 2008 Jun; 47(6):1955-63. PubMed ID: 18433021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant expression of microRNAs and the miR-1/MET pathway in canine hepatocellular carcinoma.
    Lai YC; Ushio N; Rahman MM; Katanoda Y; Ogihara K; Naya Y; Moriyama A; Iwanaga T; Saitoh Y; Sogawa T; Sunaga T; Momoi Y; Izumi H; Miyoshi N; Endo Y; Fujiki M; Kawaguchi H; Miura N
    Vet Comp Oncol; 2018 Jun; 16(2):288-296. PubMed ID: 29314614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
    Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P
    PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of microRNA expression profiles in human hepatitis B virus-related hepatocellular carcinoma.
    Li J; Shi W; Gao Y; Yang B; Jing X; Shan S; Wang Y; Du Z
    Clin Lab; 2013; 59(9-10):1009-15. PubMed ID: 24273923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
    Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
    Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of microRNAs specific for epithelial cell adhesion molecule-positive tumor cells in hepatocellular carcinoma.
    Ji J; Zheng X; Forgues M; Yamashita T; Wauthier EL; Reid LM; Wen X; Song Y; Wei JS; Khan J; Thorgeirsson SS; Wang XW
    Hepatology; 2015 Sep; 62(3):829-40. PubMed ID: 25953724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype.
    Connolly E; Melegari M; Landgraf P; Tchaikovskaya T; Tennant BC; Slagle BL; Rogler LE; Zavolan M; Tuschl T; Rogler CE
    Am J Pathol; 2008 Sep; 173(3):856-64. PubMed ID: 18688024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. microRNA expression alteration after arsenic trioxide treatment in HepG-2 cells.
    Meng XZ; Zheng TS; Chen X; Wang JB; Zhang WH; Pan SH; Jiang HC; Liu LX
    J Gastroenterol Hepatol; 2011 Jan; 26(1):186-93. PubMed ID: 21175813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-301a-3p suppressed the progression of hepatocellular carcinoma via targeting VGLL4.
    Hu J; Ruan J; Liu X; Xiao C; Xiong J
    Pathol Res Pract; 2018 Dec; 214(12):2039-2045. PubMed ID: 30322806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unique microRNA alterations in hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice.
    Yamashita H; Surapureddi S; Kovi RC; Bhusari S; Ton TV; Li JL; Shockley KR; Peddada SD; Gerrish KE; Rider CV; Hoenerhoff MJ; Sills RC; Pandiri AR
    Arch Toxicol; 2020 Jul; 94(7):2523-2541. PubMed ID: 32306082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microarray Expression Profiling of microRNAs Reveals Potential Biomarkers for Hepatocellular Carcinoma.
    Zhu HR; Huang RZ; Yu XN; Shi X; Bilegsaikhan E; Guo HY; Song GQ; Weng SQ; Dong L; Janssen HLA; Shen XZ; Zhu JM
    Tohoku J Exp Med; 2018 Jun; 245(2):89-98. PubMed ID: 29899182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma.
    Yan H; Dong X; Zhong X; Ye J; Zhou Y; Yang X; Shen J; Zhang J
    Mol Carcinog; 2014 Dec; 53(12):960-9. PubMed ID: 23861222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HDAC6 Suppresses Let-7i-5p to Elicit TSP1/CD47-Mediated Anti-Tumorigenesis and Phagocytosis of Hepatocellular Carcinoma.
    Yang HD; Kim HS; Kim SY; Na MJ; Yang G; Eun JW; Wang HJ; Cheong JY; Park WS; Nam SW
    Hepatology; 2019 Oct; 70(4):1262-1279. PubMed ID: 30991448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties.
    Chiba T; Kita K; Zheng YW; Yokosuka O; Saisho H; Iwama A; Nakauchi H; Taniguchi H
    Hepatology; 2006 Jul; 44(1):240-51. PubMed ID: 16799977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.
    Yamamoto Y; Kosaka N; Tanaka M; Koizumi F; Kanai Y; Mizutani T; Murakami Y; Kuroda M; Miyajima A; Kato T; Ochiya T
    Biomarkers; 2009 Nov; 14(7):529-38. PubMed ID: 19863192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.